Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoyong Tang

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Hybridoma (2005)|August 20, 2011
Monoclonal antibody against NRP-1 b1b2Xiang Li, Fanghong Luo, Shengyu Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2026
Treatment patterns of elderly patients with limited-stage small-cell lung cancer in real-world data: A multicentre retrospective analysisZhuoran Sun, Weikang Xin, Yaru Tian, et al.
BMC Cancer|May 3, 2026
Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center studyGuangjian Yang, Linyan Tian, Dongsheng He, et al.
Emerging Microbes & Infections|June 2, 2020
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progressionLiang Shen, Chunhua Wang, Jianzhong Zhao, et al.
International Journal of Cancer|March 21, 2026
Coronavirus disease 2019 infection reduces EGFR-TKI efficacy in non-small cell lung carcinoma: Real-world evidence from a multicenter propensity-matched cohortWenjie Tang, Xiaoxuan Hou, Li Li, et al.
BMC Cancer|April 17, 2024
Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancerXiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, et al.
Eclinicalmedicine|September 10, 2024
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trialDawei Chen, Bing Zou, Butuo Li, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in ChinaXiao Han, Jun Guo, Xiaoyong Tang, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trialXiao Han, Xiaoyong Tang, Hui Zhu, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Hybridoma (2005)|August 20, 2011
Monoclonal antibody against NRP-1 b1b2Xiang Li, Fanghong Luo, Shengyu Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 14, 2026
Treatment patterns of elderly patients with limited-stage small-cell lung cancer in real-world data: A multicentre retrospective analysisZhuoran Sun, Weikang Xin, Yaru Tian, et al.
BMC Cancer|May 3, 2026
Aumolertinib in non-small cell lung cancer with uncommon EGFR exon 19 deletions: a real-world dual-center studyGuangjian Yang, Linyan Tian, Dongsheng He, et al.
Emerging Microbes & Infections|June 2, 2020
Delayed specific IgM antibody responses observed among COVID-19 patients with severe progressionLiang Shen, Chunhua Wang, Jianzhong Zhao, et al.
International Journal of Cancer|March 21, 2026
Coronavirus disease 2019 infection reduces EGFR-TKI efficacy in non-small cell lung carcinoma: Real-world evidence from a multicenter propensity-matched cohortWenjie Tang, Xiaoxuan Hou, Li Li, et al.
BMC Cancer|April 17, 2024
Phase I/II clinical trial of efficacy and safety of EGCG oxygen nebulization inhalation in the treatment of COVID-19 pneumonia patients with cancerXiaoyan Yin, Wanqi Zhu, Xiaoyong Tang, et al.
Eclinicalmedicine|September 10, 2024
Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small-cell lung cancer (ES-SCLC): a phase II trialDawei Chen, Bing Zou, Butuo Li, et al.
Journal of Cancer Research and Clinical Oncology|April 28, 2022
Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in ChinaXiao Han, Jun Guo, Xiaoyong Tang, et al.
Journal for Immunotherapy of Cancer|January 5, 2023
Short-term dynamics of circulating tumor DNA predicting efficacy of sintilimab plus docetaxel in second-line treatment of advanced NSCLC: biomarker analysis from a single-arm, phase 2 trialXiao Han, Xiaoyong Tang, Hui Zhu, et al.
Pageof 3